Onconetix, Inc. Payment for Pension and Other Postretirement Benefits
Onconetix, Inc. (ONCO) reported Payment for Pension and Other Postretirement Benefits of $45.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:PensionAndOtherPostretirementBenefitContributions · last filed 2026-03-13
- Onconetix, Inc. payment for pension and other postretirement benefits for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Onconetix, Inc. payment for pension and other postretirement benefits for the quarter ending 2025-09-30 was $3.00K, a 86.96% decline year-over-year.
- Onconetix, Inc. payment for pension and other postretirement benefits for the quarter ending 2025-06-30 was $21.00K, a 4.55% decline year-over-year.
- Onconetix, Inc. payment for pension and other postretirement benefits for the quarter ending 2025-03-31 was $21.00K, a 1.87% decline year-over-year.
- Onconetix, Inc. payment for pension and other postretirement benefits for fiscal 2025 was $45.00K, a 49.67% decline from fiscal 2024.
- Onconetix, Inc. payment for pension and other postretirement benefits for fiscal 2024 was $89.40K.
| Period end | Payment for Pension and Other Postretirement Benefits 1 month | Payment for Pension and Other Postretirement Benefits 3 month | Payment for Pension and Other Postretirement Benefits 6 month | Payment for Pension and Other Postretirement Benefits 9 month | Payment for Pension and Other Postretirement Benefits 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $3.00K derived: sum of 2 quarters · filed 2026-03-13 | $24.00K derived: sum of 3 quarters · filed 2026-03-13 | $45.00K 10-K · filed 2026-03-13 | |
| 2025-09-30 | $3.00K 10-Q · filed 2025-11-13 | $24.00K derived: sum of 2 quarters · filed 2025-11-13 | $45.00K 10-Q · filed 2025-11-13 | $68.40K derived: sum of 4 quarters · filed 2026-03-13 | |
| 2025-06-30 | $21.00K 10-Q · filed 2025-08-14 | $42.00K 10-Q · filed 2025-08-14 | $65.40K derived: sum of 3 quarters · filed 2026-03-13 | $88.40K derived: sum of 4 quarters · filed 2026-03-13 | |
| 2025-03-31 | $21.00K 10-Q · filed 2025-06-12 | $44.40K derived: sum of 2 quarters · filed 2026-03-13 | $67.40K derived: sum of 3 quarters · filed 2026-03-13 | $89.40K derived: sum of 4 quarters · filed 2026-03-13 | |
| 2024-12-31 | $23.40K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $46.40K derived: sum of 2 quarters · filed 2026-03-13 | $68.40K derived: sum of 3 quarters · filed 2026-03-13 | $89.40K 10-K · filed 2026-03-13 | |
| 2024-09-30 | $23.00K 10-Q · filed 2025-11-13 | $45.00K derived: sum of 2 quarters · filed 2025-11-13 | $66.00K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $22.00K 10-Q · filed 2025-08-14 | $43.00K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | $21.40K 10-Q · filed 2025-06-12 | ||||
| 2023-12-31 | $0.00 10-K · filed 2025-06-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |